Dr. Mulvihill is a pediatrician and medical geneticist with 20 years' experience at the National Cancer Institute, where he was chief of the Clinical Genetics Section of the Clinical Epidemiology Branch and Director of the Interinstitute Medical Genetics Program of the National Institutes of Health. In 1990, he became founder, chair, and professor of Human Genetics at the University of Pittsburgh and Co-director of the Pittsburgh Genetics Institute. In 1998, he accepted the Children’s Medical Research Institute--Kimberly V. Talley Chair of Genetics, Professor of Pediatrics, University of Oklahoma; he is also adjunct professor of Epidemiology and Biostatistics and of Pathology.
A graduate of the College of the Holy Cross, Dartmouth Medical School, and the University of Washington, he was on the house staff at University of Washington Hospital and at the Johns Hopkins Hospital. He hs been a member of 13 professional societies, and co-founder and past president of the International Genetic Epidemiology Society. In addition to belonging to the editorial boards of eight scientific journals, he was co-editor-in-chief of Genetic Epidemiology and editor of the Neurofibromatosis Research Newsletter. In 1989, the National Neurofibromatosis Foundation awarded him its first Friedrich von Recklinghausen award. Mentoring is his major commitment.
Dr. Mulvihill’s research has focused on the genetics of human cancer, with an emphasis on late genetic and reproductive effects in cancer survivors and on germ cell mutagenesis. He maintains a unique Registry of Pregnancies Exposed to Cancer Chemotherapy. He organized the first International Conferences on the Genetics of Human Cancer in 1975 and on Neurofibromatosis in 1980 and, in Oklahoma City in 2003, an International Conference on Family Cancer. He has had National Institutes of Health and other research grants for neurofibromatosis, pancreatic cancer, and fetal alcohol syndrome and has written 334 scientific articles and edited 15 monographs. Elected a Director of the American College of Medical Genetics, he is also is a member of the Committee on Ethics, Law, and Society of the International Human Genome Organisation (HUGO) and was a Scientific Advisor of the Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.